查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497004

预填充式注射器市场：趋势、机会与竞争分析

Prefilled Syringe Market: Trends, Opportunities and Competitive Analysis
出版日期: | 出版商: Lucintel | 英文 226 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预填充式注射器市场介绍

近年来，由于医疗保健产业对方便、安全和即用型给药系统的需求不断增长，全球预填充式注射器市场出现了显着成长。与传统管瓶和注射器相比，预填充式注射器具有许多优点，包括准确剂量、降低污染风险、易于给药以及提高患者依从性。该报告提供了预填充式注射器市场的全面分析，包括市场占有率洞察、市场规模预测和详细的市场分析。

预填充式注射器市场概况

Lucintel 相信，全球预填充式注射器市场的未来性充满希望，为医院/诊所、门诊手术中心和其他最终用户提供了机会。预计到 2030 年，全球预填充式注射器市场将达到 62 亿美元，2024 年至 2030 年复合年增长率为 2.0%。该市场的主要驱动因素是慢性病盛行率的增加和家庭医疗保健市场的成长。

预填充式注射器市场经历了显着成长，预计未来将继续扩大。市场规模受到注射疗法的采用增加、生物製药开发的增加以及对自我给药设备的日益偏好等因素的影响。

预填充式注射器的新趋势

由于对安全、方便和用户友好的给药系统的需求不断增长，全球预填充式注射器市场正在显着增长。市场占有率集中在主要企业手中，他们不断投资研发以推出创新的预填充式注射器解决方案。由于慢性病盛行率上升、生物製药的发展以及对自我管理设备的日益偏好等因素，市场规模预计将显着增长。

此外，该报告还按註射器类型提供了详细的市场分析，提供了有关技术进步、市场趋势和未来成长前景的资讯。我们检验影响预填充式注射器的监管环境和品质标准，以及针头安全装置和连接解决方案等新趋势对市场的影响。

对产业动态有直接影响的新兴趋势包括使用注射器柱塞塞来增强生物製药的输送以及在预填充式注射器中使用更细的针头或微针。

在这个市场中，糖尿病是最大的应用市场，医院和诊所是最大的最终使用领域。下图描绘了预填充式注射器市场各个领域的成长。

预填充式注射器市场报告提供了有关市场趋势、竞争发展和成长机会的宝贵见解。这将使相关人员能够做出明智的决策，了解市场动态并将资金投入不断扩大的预填充式注射器市场。随着医疗保健产业继续优先考虑患者的安全和便利，预填充式注射器的采用预计会增加，从而彻底改变药物输送并改善患者的治疗效果。本研究按应用、设计、最终用途、材料、类型和地区总结了全球预填充式注射器市场趋势和预测，如下：

预填充式注射器市场占有率

预填充式注射器安装了特定剂量的药物，让医疗保健专业人员轻鬆、精确地给药或患者自行给药。它用于多种治疗领域，包括疫苗、胰岛素、抗凝血剂、生技药品和其他注射药物。该市场的驱动因素包括慢性病的增加、对安全且高效的给药系统的需求以及对患者便利性的日益关注等。

随着新参与企业的出现和受託製造厂商的扩张，预填充式注射器市场的市场动态正在不断发展。此外，製药公司和包装供应商之间的合作正在推动专门用于生技药品、生物仿製药和个人化药物的预填充式注射器的开发。

向预填充式注射器的转变是出于提高安全性、减少用药错误和改善病患体验的需求。预填充式注射器无需手动填充，并降低了剂量错误的风险，使其成为医疗保健提供者和患者的首选。此外，对以患者为中心的护理和居家医疗的日益重视也促进了市场的成长。

预填充式注射器製造商

从市场占有率来看，预填充式注射器市场主要由 Becton、Dickinson and Company、Gerresheimer AG、SCHOTT AG、West Pharmaceutical Services, Inc. 和 AptarGroup, Inc. 等主要企业主导。这些公司已成为预填充式注射器行业的领导者，提供多样化的预填充式注射器解决方案组合，满足监管要求并满足医疗保健专业人员和患者不断变化的需求。这些公司投资研发并引进创新设计、材料和技术。

同一市场中的公司根据其提供的产品品质进行竞争。该市场的主要企业专注于扩大製造设施、研发投资、基础设施开发以及利用整个价值链的整合机会。透过这些策略，预填充式注射器公司正在应对不断增长的需求，确保竞争力，开发创新产品和技术，降低生产成本，并扩大基本客群。本报告介绍的预填充式注射器公司包括：

  • Becton, Dickinson, and Company
  • Gerresheimer AG
  • B. Braun Melsungen
  • Schott AG
  • Baxter International
  • Nipro Corporation
  • Shandong Weigao Group

预填充式注射器市场洞察

  • Lucintel 预测，由于糖尿病、癌症和自体免疫疾病等慢性疾病的盛行率不断上升，传统预填充式注射器仍将是最大的细分市场，并且预计将在预测期内实现最高成长。
  • 由于注射器的使用不断增加、预填充式注射器的益处激增以及慢性病盛行率的增加，糖尿病在预测期内将继续成为最大的应用领域。
  • 由于医疗基础设施的改善、拥有先进设备的医院数量的增加以及研发部门的发展，亚太地区在预测期内可能仍然是成长最快的地区。

常见问题 (FAQ)

Q1.预填充式注射器市场规模有多大？

A1. 到 2030 年，全球预填充式注射器市场预计将达到 62 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球预填充式注射器市场预计将以2.0%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 此市场的主要驱动因素是慢性病盛行率的增加和家庭医疗保健市场的成长。

Q4.预填充式注射器市场的主要应用是什么？

A4.过敏症、糖尿病、类风湿性关节炎等是预填充式注射器的主要应用领域。

Q5.预填充式注射器市场有哪些新趋势？

A5. 对产业动态有直接影响的新兴趋势包括使用注射器柱塞塞来增强生物製药的输送以及在预填充式注射器。

Q6. 生产预填充式注射器的主要企业有哪些？

A6.预填充式注射器的主要企业如下：

  • Becton, Dickinson, and Company
  • Gerresheimer AG
  • B. Braun Melsungen
  • Schott AG
  • Baxter International
  • Nipro Corporation
  • Shandong Weigao Group

Q7. 未来预填充式注射器市场中哪一种产品类型会是最大的？

A7.Lucintel 预测，由于糖尿病、癌症和自体免疫疾病等慢性疾病的盛行率不断增加，传统的预填充式注射器仍将是最大的细分市场，并将在预测期内实现最高的成长。

Q8. 未来五年预填充式注射器市场最大的地区是？

A8.亚太地区预计在未来五年内成为最大的地区。

Q9. 可以客製化报告吗？

A9. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章 全球预填充式注射器市场背景及分类

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势和预测
  • 全球预填充式注射器市场趋势及预测
  • 材质的预填充式注射器市场
    • 玻璃底座
    • 塑胶底座
  • 按产品类型分類的预填充式注射器市场
    • 传统的
    • 安全
  • 预填充式注射器市场的设计
    • 单室
    • 双腔室
    • 客製化
  • 预填充式注射器市场的应用
    • 过敏反应
    • 糖尿病
    • 类风湿性关节炎
    • 其他用途
  • 按最终用户分類的全球预填充式注射器市场
    • 医院/诊所
    • 门诊手术中心
    • 其他最终用户

第四章 2018-2030年市场趋势及预测分析

  • 按地区分類的预填充式注射器市场
  • 北美预填充式注射器市场
  • 欧洲预填充式注射器市场
  • 亚太地区预填充式注射器市场
  • 其他地区预填充式注射器市场

第五章 竞争分析

  • 产品系列分析
  • 市场占有率分析
  • 业务整合
  • 地理范围
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球预填充式注射器市场按材料分類的成长机会
    • 按产品类型分類的全球预填充式注射器市场成长机会
    • 全球预填充式注射器市场设计成长机会
    • 全球预填充式注射器市场成长机会（按应用）
    • 最终用户的全球预填充式注射器市场成长机会
    • 全球预填充式注射器市场成长机会（按地区）
  • 全球预填充式注射器市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球预填充式注射器市场产能
    • 全球预填充式注射器市场的併购和合资企业

第七章主要企业概况

  • Gerresheimer AG
  • Schott AG
  • B. Braun Melsungen
  • Becton, Dickinson, and Company（BD）
  • West Pharmaceutical Services
  • Nipro Corporation
  • Vetter Pharma International
  • Catalent
  • Shandong Weigao Group
  • Stevanato Group（OMPI）
  • Baxter
  • Terumo Corporation
简介目录

Prefilled Syringe Market Introduction

The global prefilled syringe market has witnessed substantial growth in recent years, driven by the increasing demand for convenient, safe, and ready-to-use drug delivery systems in the healthcare industry. Prefilled syringes offer numerous advantages over traditional vials and syringes, including accurate dosing, reduced risk of contamination, ease of administration, and improved patient adherence. This report provides a comprehensive analysis of the prefilled syringe market, including market share insights, size estimations, and a detailed market analysis.

Prefilled Syringe Market Overview

Lucintel finds the future of the global prefilled syringe market looks promising with opportunities in hospital/clinics, ambulatory surgical centers and other end-users. The global prefilled syringe market is expected to reach an estimated $6.2 billion by 2030 with a CAGR of 2.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases and growing home-based healthcare market.

The prefilled syringe market has experienced significant growth and is expected to continue expanding in the coming years. The market size is influenced by factors such as the increasing adoption of injectable therapies, the rise in biologic drug development, and the growing preference for self-administration devices.

A total of 108 figures / charts and 95 tables are provided in this 226-page report to help in your business decisions. Sample figures with some insights are shown below.

Emerging Trends in Prefilled Syringe

The global prefilled syringe market is witnessing significant growth, driven by the increasing demand for safe, convenient, and user-friendly drug delivery systems. Market share is concentrated among key players, with ongoing investments in research and development to introduce innovative prefilled syringe solutions. The market size is projected to grow substantially, fueled by factors such as the rising prevalence of chronic diseases, the development of biologic drugs, and the growing preference for self-administration devices.

Furthermore, the report includes a detailed market analysis of each syringe type, providing information on technological advancements, market trends, and future growth prospects. It examines the regulatory landscape and quality standards affecting prefilled syringes, along with the impact of emerging trends such as needle safety devices and connectivity solutions on the market.

Emerging trends, which have a direct impact on the dynamics of the industry, include the usage of syringe plunger stopper for enhanced biologic drug delivery and usage of finer needles or microneedles in prefilled syringes.

In this market, diabetes is the largest application market, and hospitals/clinics is the largest end use segment. Growth in various segments of the prefilled syringe market are shown in the figure below.

Prefilled Syringe Market by Segment

The prefilled syringe market report provides valuable insights into market trends, competitive dynamics, and growth opportunities. It enables stakeholders to make informed decisions, understand market dynamics, and capitalize on the expanding prefilled syringe market. As the healthcare industry continues to prioritize patient safety and convenience, the adoption of prefilled syringes is expected to increase, revolutionizing drug delivery and improving patient outcomes. The study includes trends and forecast for the global prefilled syringe market by application, design, end use, material, type, and region as follows:

Prefilled Syringe Market by Material [Value ($M) from 2016 to 2027]:

  • Glass-Based
  • Plastic-Based

Prefilled Syringe Market by Product Type [Value ($ Million) from 2016 to 2027]:

  • Conventional
  • Safety

Prefilled Syringe Market by Design [Value ($M) from 2016 to 2027]:

  • Single-Chamber
  • Dual-Chamber
  • Customized

Prefilled Syringe Market by Application [Value ($M) from 2016 to 2027]:

  • Anaphylaxis
  • Diabetes
  • Rheumatoid Arthritis
  • Others

Prefilled Syringe Market by End User [Value ($ Million) from 2016 to 2027]:

  • Hospitals/Clinics
  • Ambulatory Surgical Centers
  • Others

Prefilled Syringe Market by Region [Value ($ Million) from 2016 to 2027]:

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • ROW
  • Brazil

Prefilled Syringe Market Share

Prefilled syringes are pre-filled with a specific dose of medication, allowing for easy and accurate administration by healthcare professionals or self-administration by patients. They are used in various therapeutic areas, including vaccines, insulin, anticoagulants, biologics, and other injectable drugs. The market is driven by factors such as the increasing prevalence of chronic diseases, the need for safe and efficient drug delivery systems, and the growing emphasis on patient convenience.

The market share dynamics within the prefilled syringe market are evolving, with the emergence of new players and the expansion of contract manufacturing organizations. Additionally, collaborations between pharmaceutical companies and packaging suppliers are driving the development of specialized prefilled syringes for biologics, biosimilars, and personalized medicines.

The shift towards prefilled syringes is driven by the need for improved safety, reduced medication errors, and enhanced patient experience. Prefilled syringes eliminate the need for manual filling and reduce the risk of dosing errors, making them a preferred choice for healthcare providers and patients alike. Moreover, the growing emphasis on patient-centric care and home healthcare further contributes to the market growth.

Prefilled Syringe Manufacturers

In terms of market share, the prefilled syringe market is dominated by key players such as Becton, Dickinson and Company, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., and AptarGroup, Inc. These companies have established themselves as leaders in the prefilled syringe industry, offering a diverse portfolio of prefilled syringe solutions that meet regulatory requirements and address the evolving needs of healthcare providers and patients. They invest in research and development to introduce innovative designs, materials, and technologies.

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, prefilled syringe companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prefilled syringe companies profiled in this report include-

  • Becton, Dickinson, and Company
  • Gerresheimer AG
  • B. Braun Melsungen
  • Schott AG
  • Baxter International
  • Nipro Corporation
  • Shandong Weigao Group

Prefilled Syringe Market Insights

  • Lucintel forecasts conventional prefilled syringes will remain the largest segment, and it is also expected to witness the highest growth over the forecast period due to increasing prevalence of chronic devices like diabetes, cancer, and autoimmune diseases.
  • Diabetes will remain the largest application segment over the forecast due to rise in adoption of injectable devices, surges in the advantages of prefilled syringes, and an increase in prevalence of chronic diseases.
  • APAC will remain the fastest growing region over the forecast period due to improvements in healthcare infrastructure, a rise in number of hospitals equipped with advanced instruments, and development of the R&D sector.

Features of the Global Prefilled Syringe Market

  • Market Size Estimates: Global prefilled syringe market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments.
  • Segmentation Analysis: Global prefilled syringe market size by material, product type, design, application, end user, and region in terms of value.
  • Regional Analysis: Global prefilled syringe market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different by material, product type, design, application, end user, and region for the global prefilled syringe market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global prefilled syringe market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model

Frequently Asked Questions (FAQ)

Q1. How big is the prefilled syringe market?

Answer: The global prefilled syringe market is expected to reach an estimated $6.2 billion by 2030.

Q2. What is the growth forecast for the prefilled syringe market?

Answer: The global prefilled syringe market is expected to grow at a CAGR of 2.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the prefilled syringe market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases and growing home-based healthcare market.

Q4. What are the major applications of the prefilled syringe market?

Answer: Anaphylaxis, diabetes, rheumatoid arthritis, and others are the major application segments of prefilled syringe.

Q5. What are the emerging trends in the prefilled syringe market?

Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include the usage of syringe plunger stopper for enhanced biologic drug delivery and usage of finer needles or microneedles in prefilled syringes.

Q6. Who are the key prefilled syringe companies?

Answer: Some of the key prefilled syringe companies are as follows:

  • Becton, Dickinson, and Company
  • Gerresheimer AG
  • B. Braun Melsungen
  • Schott AG
  • Baxter International
  • Nipro Corporation
  • Shandong Weigao Group

Q7. Which will be the largest product type segment of the prefilled syringe market in the future?

Answer: Lucintel forecasts that conventional prefilled syringes will remain the largest segment, and it is also expected to witness the highest growth over the forecast period due to increasing prevalence of chronic devices like diabetes, cancer, and autoimmune diseases.

Q8.In prefilled syringe market, which region is expected to be the largest in the next five years?

Answer: Asia Pacific is expected to be the largest region over the next five years.

Q9. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising growth opportunities for the global prefilled syringe market by material (glass-based and plastic-based), product type (conventional and safety), design (single chamber, dual chamber, and customized), application (anaphylaxis, diabetes, rheumatoid arthritis, and others), end user (hospitals/clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2 Which segments will grow at a faster pace and why?
  • Q.3 Which region will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global prefilled syringe market?
  • Q.5 What are the business risks and threats to the global prefilled syringe market?
  • Q.6 What are the emerging trends in this prefilled syringe market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the prefilled syringe market?
  • Q.8 What are the new developments in the prefilled syringe market? Which companies are leading these developments?
  • Q.9 Who are the major players in the prefilled syringe market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in the prefilled syringe market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M&A activities did take place in the last five years in the global prefilled syringe market?

Table of Contents

1. Executive Summary

2. Global Prefilled Syringe Market Background and Classifications

  • 2.1: Introduction, Background, and Classification
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1: Macroeconomic Trends and Forecasts
  • 3.2: Global Prefilled Syringe Market Trends and Forecast
  • 3.3: Global Prefilled Syringe Market by Material
    • 3.3.1: Glass-Based
    • 3.3.2: Plastic-Based
  • 3.4: Global Prefilled Syringe Market by Product Type
    • 3.4.1: Conventional
    • 3.4.2: Safety
  • 3.5: Global Prefilled Syringe Market by Design
    • 3.5.1: Single-Chamber
    • 3.5.2: Dual-Chamber
    • 3.5.3: Customized
  • 3.6: Global Prefilled Syringe Market by Application
    • 3.6.1: Anaphylaxis
    • 3.6.2: Diabetes
    • 3.6.3: Rheumatoid Arthritis
    • 3.6.4: Other Applications
  • 3.7: Global Prefilled Syringe Market by End-User
    • 3.7.1: Hospitals/Clinics
    • 3.7.2: Ambulatory Surgical Centers
    • 3.7.3: Other End-Users

4. Market Trends and Forecast Analysis from 2018 to 2030

  • 4.1: Global Prefilled Syringe Market by Region
  • 4.2: North American Prefilled Syringe Market Trends and Forecast
    • 4.2.1: Market by Material: Glass-Based and Plastic-Based
    • 4.2.2: Market by Product Type: Conventional Prefilled Syringes and Safety Prefilled Syringes
    • 4.2.3: Market by Design: Single-Chamber, Dual-Chamber, and Customized
    • 4.2.4: Market by Application: Anaphylaxis, Rheumatoid Arthritis, Diabetes and Others
    • 4.2.5: Market by End-User: Hospitals/Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Prefilled Syringe Market Trends and Forecast
    • 4.3.1: Market by Material: Glass-Based and Plastic-Based
    • 4.3.2: Market by Product Type: Conventional Prefilled Syringes and Safety Prefilled Syringes
    • 4.3.3: Market by Design: Single-Chamber, Dual-Chamber, and Customized
    • 4.3.4: Market by Application: Anaphylaxis, Diabetes, Rheumatoid Arthritis, and Others
    • 4.3.5: Market by End-User: Hospitals/Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Prefilled Syringe Market Trends and Forecast
    • 4.4.1: Market by Material: Glass-Based and Plastic-Based
    • 4.4.2: Market by Product Type: Conventional Prefilled Syringes and Safety Prefilled Syringes
    • 4.4.3: Market by Design: Single-Chamber, Dual-Chamber, and Customized
    • 4.4.4: Market by Application: Anaphylaxis, Diabetes, Rheumatoid Arthritis, and Others
    • 4.4.5:Market by End-User: Hospitals/Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Prefilled Syringe Market Trends and Forecast
    • 4.5.1: Market by Material: Glass-Based and Plastic-Based
    • 4.5.2: Market by Product Type: Conventional Prefilled Syringes and Safety Prefilled Syringes
    • 4.5.3: Market by Design: Single-Chamber, Dual-Chamber, and Customized
    • 4.5.4: Market by Application: Anaphylaxis, Diabetes, Rheumatoid Arthritis, and Others
    • 4.5.5: Market by End-User: Hospitals/Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Operational Integration
  • 5.4: Geographical Reach
  • 5.5: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Prefilled Syringe Market by Material
    • 6.1.2: Growth Opportunities for the Global Prefilled Syringe Market by Product Type
    • 6.1.3: Growth Opportunities for the Global Prefilled Syringe Market by Design
    • 6.1.4: Growth Opportunities for the Global Prefilled Syringe Market by Application
    • 6.1.5: Growth Opportunities for the Global Prefilled Syringe Market by End-User
    • 6.1.6: Growth Opportunities for the Global Prefilled Syringe Market by Region
  • 6.2: Emerging Trends in the Global Prefilled Syringe Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Prefilled Syringe Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prefilled Syringe Market

7. Company Profiles of Leading Players

  • 7.1: Gerresheimer AG
  • 7.2: Schott AG
  • 7.3: B. Braun Melsungen
  • 7.4: Becton, Dickinson, and Company (BD)
  • 7.5: West Pharmaceutical Services
  • 7.6: Nipro Corporation
  • 7.7: Vetter Pharma International
  • 7.8: Catalent
  • 7.9: Shandong Weigao Group
  • 7.10: Stevanato Group (OMPI)
  • 7.11: Baxter
  • 7.12: Terumo Corporation